Companies across the globe are re-examining their takeover defences in the face of an anticipated surge in unsolicited bids from predators while share prices remain low.

Such reviews come at a time when the vulnerability of companies to hostile bids has increased over recent years in response to corporate governance activists who have criticised traditional takeover defences such as poison pills.